Ribosomal protection as a linezolid resistance mechanism in <i>Mycobacterium abscessus</i>

<i>Mycobacterium abscessus</i> has emerged as a significant pulmonary pathogen characterized by its resistance to most first-line antimycobacterial drugs. Recent investigations have highlighted the clinical efficacy of including the oxazolidinone antibiotic linezolid in <i>M. abscessus</i> combination therapies, despite moderate resistance frequently being observed in patient isolates. Even with the potential usefulness of linezolid, the mechanisms that drive linezolid resistance in <i>M. abscessus</i> remain poorly understood. In several bacterial pathogens, including <i>Mycobacterium tuberculosis</i>, ATP-binding cassette (ABC) family proteins of the F subtype (ABC-F) have been found to confer antibiotic resistance to ribosome-targeting antibiotics, including linezolid. Here, we identified an <i>M. abscessus</i> ABC-F protein, MAB_2736c, that causes specific resistance to antibiotics that bind the 50S ribosomal subunit, including linezolid, macrolides, and chloramphenicol. These results demonstrate that targeting ABC-F proteins could help combat intrinsic resistance to several ribosome-targeting antibiotics in mycobacteria.

Authors

Institutions

Publication Details

Journal
Antimicrobial Agents and Chemotherapy
Published
2026-03-02
DOI
https://doi.org/10.1128/aac.01605-25
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ribosomal protection as a linezolid resistance mechanism in Mycobacterium abscessus

Kerry McGowen, Mark R. Sullivan, Dennis Nurjadi, Samuel Zinga et al.
Antimicrobial Agents and Chemotherapy
Tuberculosis Research and Epidemiology
article

Ribosomal protection as a linezolid resistance mechanism in Mycobacterium abscessus

Kerry McGowen, Mark R. Sullivan, Dennis Nurjadi, Samuel Zinga, Tobias Funck, Claudia M. Denkinger, Eric J. Rubin, Ian D. Wolf
article en

Abstract

<i>Mycobacterium abscessus</i> has emerged as a significant pulmonary pathogen characterized by its resistance to most first-line antimycobacterial drugs. Recent investigations have highlighted the clinical efficacy of including the oxazolidinone antibiotic linezolid in <i>M. abscessus</i> combination therapies, despite moderate resistance frequently being observed in patient isolates. Even with the potential usefulness of linezolid, the mechanisms that drive linezolid resistance in <i>M. abscessus</i> remain poorly understood. In several bacterial pathogens, including <i>Mycobacterium tuberculosis</i>, ATP-binding cassette (ABC) family proteins of the F subtype (ABC-F) have been found to confer antibiotic resistance to ribosome-targeting antibiotics, including linezolid. Here, we identified an <i>M. abscessus</i> ABC-F protein, MAB_2736c, that causes specific resistance to antibiotics that bind the 50S ribosomal subunit, including linezolid, macrolides, and chloramphenicol. These results demonstrate that targeting ABC-F proteins could help combat intrinsic resistance to several ribosome-targeting antibiotics in mycobacteria.

Antimicrobial Agents and Chemotherapy
Harvard University (US), Heidelberg University (DE), University Hospital Heidelberg (DE), University Hospital Schleswig-Holstein (DE), German Center for Infection Research (DE), University of Lübeck (DE)
Good health and well-being
Openalex Percentile: Top 38%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Ribosomal protection as a linezolid resistance mechanism in <i>Mycobacterium abscessus</i> — Kerry McGowen, Mark R. Sullivan, et al. · Antimicrobial Agents and Chemotherapy (2026) | TGRS Research Map | TGRS